Patents by Inventor Marc Cantin

Marc Cantin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11377224
    Abstract: A system comprising a trolley which comprises a platform and wheels attached beneath the platform, an air intake of an aircraft engine, where the air intake rests on the platform so as to have its narrowest part at the top and its widest part at the bottom, and an inflatable protection item in the form of a closed envelope which is placed around the widest part of the air intake. A system of this kind makes it possible to protect the air intake from collisions that it might experience during movement of the trolley, and to increase safety by avoiding collisions between operators and the air intake.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: July 5, 2022
    Assignee: Airbus Operations SAS
    Inventors: Jean-Marc Cantin, Olivier Dubois
  • Publication number: 20200262572
    Abstract: A system comprising a trolley which comprises a platform and wheels attached beneath the platform, an air intake of an aircraft engine, where the air intake rests on the platform so as to have its narrowest part at the top and its widest part at the bottom, and an inflatable protection item in the form of a closed envelope which is placed around the widest part of the air intake. A system of this kind makes it possible to protect the air intake from collisions that it might experience during movement of the trolley, and to increase safety by avoiding collisions between operators and the air intake.
    Type: Application
    Filed: January 31, 2020
    Publication date: August 20, 2020
    Inventors: Jean-Marc CANTIN, Olivier DUBOIS
  • Patent number: 4607023
    Abstract: Novel peptides in substantially pure form and selected from the group of peptides having the amino acid sequence:X-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Y-ZwhereinY is selected from the group consisting of -Asn, -Asn-Ser, -Asn-Ser-Phe, -Asn-Ser-Phe-Arg, and -Asn-Ser-Phe-Arg-Tyr;Z is OH or NH.sub.2 ; andX is selected from the group consisting of H, Ser-, Ser-Ser-, Arg-Ser-Ser-, Arg-Arg-Ser-Ser-, Leu-Arg-Arg-Ser-Ser, Ser-Leu-Arg-Arg-Ser-Ser-, Arg-Ser-Leu-Arg-Arg-Ser-Ser-, Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-, Gly-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser, Ala-Gly-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-, Leu-Ala-Gly-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser, and Glu-Val-Pro-Trp-Thr-Gly-Glu-Val-Asn-Pro-Ser-Gln-Arg-Asp-Gly-Gly-Ala-Leu-Gl y-Arg-Gly-Pro-Trp-Asp-Pro-Ser-Asp-Arg-Ser-Ala-Leu-Lys-Ser-Lys-Leu-Arg-Ala-L eu-Leu-Ala-Gly-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-,are disclosed as having diuretic, natriuretic, vasorelaxant, hypotensive or anti-hypertensive properties.
    Type: Grant
    Filed: August 27, 1984
    Date of Patent: August 19, 1986
    Assignee: L'Institut de Recherches Cliniques de Montreal
    Inventors: Gaetan Thibault, Raul Garcia, Marc Cantin, Nabil Seidah, Claude Lazure, Michel Chretien